Company Number: 13852823

Analysis Date: 2025-07-20 17:06 UTC

Financial Health Assessment Report for VITALSCAN LIMITED
(As at 31 January 2024)

---

1. Financial Health Score: C

Explanation:
VITALSCAN LIMITED demonstrates a mixed financial condition. While it shows substantial investment in fixed assets and an expanding workforce, it also exhibits signs of financial strain in working capital and retained earnings, reflected in a reduced net asset base and a significant accumulated loss. The company is currently active and compliant with filing obligations, which is positive. However, the sharp decline in current assets and cash balances, alongside growing liabilities, suggest symptoms of liquidity stress that require careful management.

---

2. Key Vital Signs

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Fixed Assets	599,106	47,694	Large increase reflecting capital investment—healthy for growth but requires financing.
Current Assets	246,661	990,199	Significant decrease, especially cash—from £440k to £47k—indicates tightening liquidity.
Cash at Bank	47,374	440,178	Sharp drop is a critical red flag for cash flow health.
Debtors	199,287	550,021	Reduction, but still relatively high; risk of delayed collections.
Current Liabilities	214,207	72,542	Increased almost threefold, increasing short-term obligations.
Net Current Assets (Working Capital)	32,454	917,657	Drastic drop signals working capital stress; limited buffer for daily operations.
Total Assets less Current Liabilities	631,560	965,351	Decline indicates overall asset base less short-term debts shrinking.
Creditors due after one year (Long-term liabilities)	335,395	256,032	Increase suggests more long-term debt or finance leases—potential gearing risk.
Deferred Tax Liability	113,937	0	New deferred tax liability impacts net assets and future cash flows.
Net Assets (Equity)	130,748	646,399	Severe reduction in net equity—potential symptom of accumulated losses.
Shareholders’ Funds	849,991	849,991	Stable nominal share capital and premium, but erosion in profit reserves.
Profit & Loss Reserve	(719,251)	(203,600)	Large accumulated losses (“sickness” in profit retention).
Average Employees	7	5	Growing team size—positive for operations but adds to fixed costs.

---

3. Diagnosis

Overall Financial Condition:
VITALSCAN LIMITED’s financial health reveals a patient experiencing both growth trauma and liquidity stress. The company has invested heavily in tangible assets (fixed assets rising from £47k to nearly £600k), indicating an expansion phase or capital build-out, which is positive from a growth perspective. However, this investment appears to be largely financed through increased liabilities, both short-term and long-term, creating a heavier debt burden.

The "symptoms" of distress are primarily seen in the liquidity and working capital metrics: cash reserves have plummeted by almost 90%, and net current assets have fallen sharply, signaling that the company may struggle to meet short-term obligations without additional financing or cash inflows.

Furthermore, the large negative profit and loss reserve indicates the company has accumulated losses, which erodes shareholders’ equity and may limit financial flexibility. The recognition of a significant deferred tax liability adds to the future cash outflow burden.

On the positive side, the company remains compliant with filing deadlines and maintains an active status. The increase in employee numbers aligns with business growth but also raises fixed costs, which must be managed carefully given the liquidity constraints.

Key Risks:

• Liquidity risk due to low cash and working capital.
• High gearing from increased long-term liabilities.
• Accumulated losses reducing equity cushion.
• Potential pressure on credit terms from suppliers and financiers.

---

4. Recommendations

1. Improve Cash Flow Management:

   • Tighten debtor collection processes to accelerate cash inflows.
   • Review payment terms with suppliers to extend payables where possible.
   • Implement detailed cash flow forecasting to avoid surprises.

2. Cost Control:

   • Monitor and manage rising employee and fixed costs carefully to avoid exacerbating cash strain.
   • Consider temporary cost-saving measures during liquidity crunches.

3. Debt Restructuring:

   • Engage with lenders to explore options for refinancing or extending repayment terms on long-term debt and finance leases.
   • Avoid taking on new debt until cash flow stabilizes.

4. Capital Injection Options:

   • Evaluate the possibility of raising new equity capital to strengthen the balance sheet and reduce reliance on debt.

5. Profitability Focus:

   • Develop strategies to improve operational profitability to reverse the trend in accumulated losses.
   • Review pricing, sales strategy, and cost efficiencies.

6. Ongoing Monitoring:

   • Regularly review financial statements and key metrics to detect early warning signs of financial stress.
   • Consider engaging with a financial advisor for detailed scenario planning.

---

Medical Analogy Summary

VITALSCAN LIMITED is like a patient undergoing rapid growth (capital investments and increased workforce), but showing symptoms of stress—low “blood pressure” of cash flow and “weak pulse” in working capital. The company’s “immune system” (shareholders’ equity) is weakened due to accumulated losses, making it vulnerable to external shocks. Immediate intervention to stabilize liquidity and control costs is essential to avoid worsening the condition.

---